Free Trial
NASDAQ:PAHC

Phibro Animal Health (PAHC) Stock Price, News & Analysis

Phibro Animal Health logo
$22.50 -0.47 (-2.05%)
Closing price 04:00 PM Eastern
Extended Trading
$22.21 -0.29 (-1.29%)
As of 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Phibro Animal Health Stock (NASDAQ:PAHC)

Key Stats

Today's Range
$22.31
$23.20
50-Day Range
$20.05
$26.22
52-Week Range
$11.98
$26.55
Volume
292,701 shs
Average Volume
222,144 shs
Market Capitalization
$911.25 million
P/E Ratio
46.88
Dividend Yield
2.13%
Price Target
$21.00
Consensus Rating
Reduce

Company Overview

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Phibro Animal Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
78th Percentile Overall Score

PAHC MarketRank™: 

Phibro Animal Health scored higher than 78% of companies evaluated by MarketBeat, and ranked 233rd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Phibro Animal Health has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Phibro Animal Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Phibro Animal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Phibro Animal Health are expected to grow by 4.62% in the coming year, from $1.95 to $2.04 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Phibro Animal Health is 46.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.56.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Phibro Animal Health is 46.88, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.46.

  • Price to Earnings Growth Ratio

    Phibro Animal Health has a PEG Ratio of 0.47. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Phibro Animal Health has a P/B Ratio of 3.69. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.85% of the float of Phibro Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Phibro Animal Health has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Phibro Animal Health has recently decreased by 5.27%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Phibro Animal Health pays a meaningful dividend of 1.99%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Phibro Animal Health does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Phibro Animal Health is 100.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 23.53% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.

  • Read more about Phibro Animal Health's dividend.
  • Percentage of Shares Shorted

    3.85% of the float of Phibro Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Phibro Animal Health has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Phibro Animal Health has recently decreased by 5.27%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Phibro Animal Health has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Phibro Animal Health this week, compared to 3 articles on an average week.
  • Search Interest

    6 people have searched for PAHC on MarketBeat in the last 30 days.
  • MarketBeat Follows

    5 people have added Phibro Animal Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Phibro Animal Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    50.07% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Phibro Animal Health's insider trading history.
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Stock News Headlines

NVDA Crash Update
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investors worrying – Is this the end of the great AI bull run?
See More Headlines

PAHC Stock Analysis - Frequently Asked Questions

Phibro Animal Health's stock was trading at $21.00 at the start of the year. Since then, PAHC stock has increased by 7.1% and is now trading at $22.50.
View the best growth stocks for 2025 here
.

Phibro Animal Health Co. (NASDAQ:PAHC) released its quarterly earnings results on Wednesday, February, 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a trailing twelve-month return on equity of 25.35% and a net margin of 1.75%.

Top institutional shareholders of Phibro Animal Health include Vanguard Group Inc. (3.74%), Pzena Investment Management LLC (3.22%), Dimensional Fund Advisors LP (1.77%) and Brandes Investment Partners LP (1.63%).
View institutional ownership trends
.

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Solid Power (SLDP), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), AT&T (T) and Advanced Micro Devices (AMD).

Company Calendar

Ex-Dividend for 12/18 Dividend
11/27/2024
Dividend Payable
12/18/2024
Last Earnings
2/05/2025
Today
2/21/2025
Ex-Dividend for 3/26 Dividend
3/05/2025
Dividend Payable
3/26/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PAHC
Employees
1,940
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$21.00
High Stock Price Target
$25.00
Low Stock Price Target
$15.00
Potential Upside/Downside
-6.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
4 Analysts

Profitability

Net Income
$2.42 million
Pretax Margin
3.05%

Debt

Sales & Book Value

Annual Sales
$1.02 billion
Cash Flow
$1.97 per share
Book Value
$6.09 per share

Miscellaneous

Free Float
20,223,000
Market Cap
$911.25 million
Optionable
Optionable
Beta
0.52

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:PAHC) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners